---
title: "A study of early predictors (Comorbidities and Etiology) of patient's outcome after cirrhosis hospitalization"
subtitle: "Group 19"
format: 
  revealjs:
    embed-resources: true
    slide-number: c/t
    theme: moon
    width: 1600
    height: 900
    mainfont: avenir
author:
  "Eva Frossard,
  Pauline Charpentier,
  Noy Tabul,
  Fabian Ziegler"
---

## Introduction 

<u>Objective: </u> Understand patterns and correlations between early predictors
**Comorbidities and Etiologies**, their numerical estimate **CPS and Charlson index** 
and **cirrhosis' patients outcome** \  

:::: {.columns}

::: {.column width="50%"}

**Cirrhosis** = condition in which the liver is scarred and permanently damaged.

<u>Relevancy of the study: </u> Cirrhosis is a leading cause of mortality in the 
world (11th), and finding accurate descriptive index is a useful tool to 
investigate the possible outcome of patients. 

:::

::: {.column width="50%"}

![](../doc/scheme.png){width="100%"}

:::
:::: 

## Materials - Dataset

:::: {.columns}
::: {.column width="60%"}
<u> Data set used: </u> [Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals](https://datadryad.org/stash/dataset/doi:10.5061/dryad.6gt88dv)

- 733 patients 
- From 4 safety-net hospitals in the US    
- Male dominated study (67.31%)
- Predominant age group [60; 70]
- Main liver disease diagnosis 
  * Ascites (31%)
  * Hepatic encephalopathy (21.2%)
  * UGIB (19.9%)
:::

::: {.column width="40%"}
![](../results/plots/Age_gender2.png){width="100%"}

![](../results/plots/Overview_LD.png){width="100%"}
:::

:::: 

## Methods

:::: {.columns}

::: {.column width="50%"}

<b>Cleaning: </b>

- Extracting, renaming, reordering columns
- Dropping non-available values them

<b>Tidying:</b>

- Pivot_wider on Comorbidities
- Pivot_wider on Etiologies

<b>Augmenting:</b>

-   Created categories for Mortality: no death, death in hospital, after 30 days, after 90 days
-   Creating age bins instead decade
:::

::: {.column width="50%"}

![](../doc/workflow.png){width="100%"}
:::

::::

## Overview of comorbidities and etiologies

-   **Etiology** is the study of the factors that come together leading to a disease.

-   **Comorbidity** is an additional disease that can interact and coexist simultaneously with cirrhosis.

::: columns
::: {.column width="50%"}
![](../results/plots/Overview_Etiology.png){width="100%"}
:::

::: {.column width="50%"}
![](../results/plots/Overview_Comorbidities.png){width="100%"}
:::
:::

## Results: Different outcomes tendency depending on the liver disease

:::: {.columns}

::: {.column width="50%"}
![](../results/plots/LD_Mortality.png){width="100%"}

:::

::: {.column width="50%"}
- 
- 
- 
:::
::::

## Death ratios of every Etiology/Liver disease combination

:::: {.columns}

::: {.column width="60%"}
![](../results/plots/Tile_plot_mortality.png){width="100%"}

:::

::: {.column width="40%"}
- 
- 
- 
:::
::::


## Model 1 - Logistic regression

::: columns
::: {.column width="70%"}

![](../results/plots/mortality_CPS.png){width="80%"}

![](../results/plots/boxplot_logistic_confidence_interval.png){width="100%"}
:::


::: {.column width="30%"}

-   **Overview:** Logistic regression model

-   **Variables:** CPS & Mortality

-   **Results:** For every increased CPS unit, the likelihood for mortality increase by 50 %
:::
:::

## Model 2 - Linear regression

::: columns
::: {.column width="60%"}
![](../results/plots/Significance_plot_CPS.png){width="100%"}
:::

::: {.column width="40%"}
-   **Overview:** Linear regression model

-   **Variables:** CPS & Etiologies

-   **Results:** Statistically significant result for nafld associated with low CPS
:::
:::

## Conclusion

-   

- 

-   

- 


